Loading viewer...
investor_presentation
Format: PDF investor_presentation
MANITEX INTERNATIONAL, INC. NASDAQ: MNTX Third Quarter 2021 Earnings Conference Call November 8, 2021
MANITEX INTERNATIONAL, INC.
Third Quarter 2021 Earnings Conference Call
Forward-Looking Statement and Non-GAAP Measures
Safe Harbor Statement under the U.S. Private Securities Litigation Reform Act of 1995: This presentation contains statements that are forward-looking in nature
which express the beliefs and expectations of management including statements regarding the Company’s expected results of operations or liquidity; statements
concerning projections, predictions, expectations, estimates or forecasts as to our business, financialand operational results and futureeconomicperformance; and
statements of management’s goals and objectives and other similar expressions concerning matters that are not historical facts. In some cases, you can identify
forward-looking statements by terminology such as “anticipate,” “estimate,” “plan,” “project,” “continuing,” “ongoing,” “expect,” “we believe,” “we intend,” “may,” “will,”
“should,” “could,” and similar expressions. Such statements are based on current plans, estimates and expectations and involve a number of known and unknown
risks, uncertainties and other factors that could cause the Company's future results, performance or achievements to differ significantly from the results,
performance or achievements expressed or implied by such forward-looking statements. These factors and additional information are discussed in the Company's
filings with the Securities and Exchange Commission and statements in this presentation should be evaluated in light of these important factors. Although we
believe that these statements are based upon reasonable assumptions, we cannot guarantee future results. Forward-looking statements speak only as of the date
on which they are made, and the Company undertakes no obligation to update publicly or revise any forward-looking statement, whether as a result of new
information,futuredevelopmentsor otherwise.
Third quarter net sales increased 39.7% year-over-year, to $50.9 million, compared to
$36.5 million in 2020
Gross profit rose 20.7%, to $8.0 million, versus $6.7 million in the fiscal third quarter of
Adjusted EBITDA* was $1.6 million in the third quarter of fiscal 2021 versus $1.0 million in
Net debt was $26.5 million at the end of the quarter, representing a leverage ratio of less
than 3.0 times trailing Adjusted EBITDA*
$113.6 million backlog remains at 5-year high
European business now more than 60% of total backlog
North America backlog up 66% YTD
Balance Sheet and Credit
$26.5 million Total Net Debt
$33 million in Total Cash and Credit Availability
Managing working capital while dealing with
supply chain issuesOperations
Order pipeline remains robust
Preview truncated — download the full document for the complete content.
investor_presentation
27 Pages
investor_presentation
11 Pages
Varian Medical Systems, Inc.
investor_presentation
Minerals 260 Limited